Compounding Pharmacy · Est. 2003 · Egg Harbor Township, NJ · 503A

Curexa Pharmacy Review

Curexa Pharmacy is a PCAB-accredited and LegitScript-certified 503A compounding pharmacy in Egg Harbor Township, New Jersey, founded in 2003, that compounds prescriptions nationwide including GLP-1 weight-loss medications such as semaglutide and tirzepatide. It is a frequently named back-end fulfillment pharmacy for telehealth platforms.

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

503APCABLegitScript
Location: Egg Harbor Township, NJ
Website: curexa.com
States licensed: 0
7.0
★★★★☆3.5/5

Editorial score · methodology

Top-Rated GLP-1 Partners

Not sourced from Curexa Pharmacy — these are our highest-scored vetted telehealth partners for compounded GLP-1s, if you'd rather start with a provider we've walked through end to end.

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

No insurance needed · HSA/FSA eligible · vetted by our editors

6.9

YourEra

$99 first-month entry pricing on compounded GLP-1s

Starting price: $149/mo

Get started →Read review YourEra →
8.2

Gala

Compounded GLP-1/GIP combo on a yearly plan with free shipping

Starting price: $149/mo

Get started →Read review Gala →
6.9

TMates

Nationwide compounded GLP-1 availability including Puerto Rico

Starting price: $249/mo

Get started →Read review TMates →
7.7

Ro

FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help

Starting price: $149/mo

Get started →Read review Ro →

Certifications & Compliance

All sterile compounding pharmacies in the United States are required to follow United States Pharmacopeia General Chapter <797> sterile compounding standards[4], with finished preparations evaluated against USP <71> sterility testing[5] and USP <85> bacterial endotoxin testing[6] as appropriate for the product type.

PCAB
Pharmacy Compounding Accreditation Board — voluntary third-party accreditation (operated by ACHC) auditing the pharmacy against nationally recognized quality and safety standards for sterile and non-sterile compounding.
LegitScript
LegitScript Healthcare Merchant certification — third-party vetting of the pharmacy's licensure, prescription requirements, and marketing practices; required by most ad platforms before a pharmacy can advertise.

Drugs Produced

Compounding pharmacies' ability to produce semaglutide or tirzepatide depends on the FDA Drug Shortage List status for each reference product; compounding eligibility can change when a drug moves on or off the shortage list[7].

Semaglutide
Compounded semaglutide produced
Tirzepatide
Compounded tirzepatide produced

States Licensed

Curexa Pharmacy has not published a state-by-state licensure list. Verify licensure for your state directly with your state board of pharmacy before filling a prescription here.

Regulatory Actions

No public FDA enforcement actions or recalls are on file in our records for Curexa Pharmacy. Regulatory status can change — verify with the FDA and your state board of pharmacy before relying on this information.

Weight Loss Rankings Score Breakdown

Accreditation & Compliance9/10
Regulatory Standing9/10
State Coverage0/10
GLP-1 Production10/10
Track Record9/10

Scores are independently researched. See our methodology for details.

Medium confidence · Last verified June 2026 · How we verify provider data

Frequently Asked Questions

Curexa Pharmacy is a 503A compounding pharmacy based in Egg Harbor Township, NJ that has been operating since 2003. It holds PCAB accreditation, a voluntary third-party quality standard for compounding pharmacies. We are not aware of any recent public FDA enforcement actions against the pharmacy, though compounding pharmacy regulatory history can change. Always verify current status with your state board of pharmacy.
Curexa Pharmacy is headquartered in Egg Harbor Township, NJ. The pharmacy is licensed to ship to 0 US states.
Curexa Pharmacy produces compounded semaglutide and compounded tirzepatide in addition to other compounded preparations. As a 503A pharmacy, it dispenses compounded medications in response to individual patient prescriptions under state board of pharmacy oversight.
503A pharmacies prepare compounded medications for individual patients in response to specific prescriptions and are regulated primarily by state boards of pharmacy under USP <797> sterile compounding standards. 503B outsourcing facilities register directly with the FDA, follow current Good Manufacturing Practices (cGMP), and can produce compounded medications in larger batches without patient-specific prescriptions. 503B facilities are subject to FDA inspection.

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

See Top Semaglutide ProvidersAll Pharmacies
Sources & methodology — as of October 2026
  1. 1.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
  2. 2.FDA — 503B Outsourcing Facility Registration and Requirements— U.S. Food & Drug Administration.
  3. 3.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
  4. 4.USP General Chapter <797> — Pharmaceutical Compounding: Sterile Preparations— United States Pharmacopeia.
  5. 5.USP General Chapter <71> — Sterility Tests— United States Pharmacopeia.
  6. 6.USP General Chapter <85> — Bacterial Endotoxins Test— United States Pharmacopeia.
  7. 7.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.